TY - JOUR
T1 - Ophthalmology and SARS-CoV-2
T2 - Blind toward those who fight blindness?
AU - Arrigo, Alessandro
AU - Aragona, Emanuela
AU - Parodi, Maurizio Battaglia
AU - Loperfido, Francesco
AU - Bandello, Francesco
N1 - Publisher Copyright:
© The Author(s) 2020.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - SARS-CoV-2 infection recently reached pandemic proportions, with high risk of death for the worldwide population. In this dramatic scenario, all the resources are addressed to the intensive care units for the assessment of the emergency. However, more attention should be paid with respect to the risk of viral diffusion among asymptomatic people. Italy is the second most involved country in the world, and we needed to gain a lot of experience in a very limited time. At least 1 m of distance among people is recommended; however, some clinical practices cannot allow this distance. In this context, we believe that the careful safety assessment of clinical settings, like ophthalmologic ones, may have a remarkable impact on the fight against SARS-CoV-2 spread.
AB - SARS-CoV-2 infection recently reached pandemic proportions, with high risk of death for the worldwide population. In this dramatic scenario, all the resources are addressed to the intensive care units for the assessment of the emergency. However, more attention should be paid with respect to the risk of viral diffusion among asymptomatic people. Italy is the second most involved country in the world, and we needed to gain a lot of experience in a very limited time. At least 1 m of distance among people is recommended; however, some clinical practices cannot allow this distance. In this context, we believe that the careful safety assessment of clinical settings, like ophthalmologic ones, may have a remarkable impact on the fight against SARS-CoV-2 spread.
KW - cornea/external disease
KW - COVID-19
KW - eyelid disease: infections/inflammations
KW - immunology
KW - infectious diseases affecting lid/conjunctiva
KW - preventive medicine/screening
UR - http://www.scopus.com/inward/record.url?scp=85085358351&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085358351&partnerID=8YFLogxK
U2 - 10.1177/1120672120929961
DO - 10.1177/1120672120929961
M3 - Article
C2 - 32450718
AN - SCOPUS:85085358351
VL - 30
SP - 1185
EP - 1187
JO - European Journal of Ophthalmology
JF - European Journal of Ophthalmology
SN - 1120-6721
IS - 5
ER -